How the drug services industry found itself prepared for a pandemic
C&EN, 26 September 2021
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
C&EN, 26 September 2021
Pharmaceutical Technology, October 2, 2018
Commitment to partnership and joint innovation for cell and gene therapies
Hovione today announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®
Watch our special message with Constança Cacela
The agreement provides Hovione with the capability to develop chemistry-in-water, enabling a significant reduction in carbon footprint compared to conventional chemical processes relying on traditional organic solvents.
A strategic partnership that will take Hovione to new technology frontiers.
Hovione announced today that it held on June 8th the official groundbreaking for the expansion of its New Jersey facility in East Windsor, USA